stockrowElanco Animal Health Incorporated
ELAN Healthcare Drug Manufacturers Specialty & Generic
Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.
- Revenue
- +11.3%
- EPS
- +157.1%
- Free cash flow
- +35.6%
- Total debt
- −6.91%
Quarter to September 2026, against a year earlier
Follow ELAN
Alert me
Elanco Animal Health Incorporated (ELAN) Gross margin
Elanco Animal Health Incorporated's gross margin over the twelve months to 30 September 2026 was 56.2%, up 1.2 percentage points from fiscal 2025 (55.0%). Over the past ten years it has ranged from 47.3% (fiscal 2015) to 56.6% (fiscal 2022); the current reading is higher than 73% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 53.5% and in line with the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 55.0% | 0.11 |
| FY2024 | 54.9% | (1.40) |
| FY2023 | 56.3% | (0.35) |
| FY2022 | 56.6% | 1.38 |
| FY2021 | 55.3% | 6.21 |
| FY2020 | 49.0% | (3.09) |
| FY2019 | 52.1% | 3.45 |
| FY2018 | 48.7% | 0.39 |
| FY2017 | 48.3% | (3.35) |
| FY2016 | 51.6% | 4.36 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 56.9% | (1.41) |
| Jun 2026 | 58.3% | 1.07 |
| Mar 2026 | 57.3% | 5.77 |
| Dec 2025 | 51.5% | (1.90) |
| 32 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 97.8% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 90.2% |
| ALKS Alkermes plc compare | 82.9% |
| HIMS Hims & Hers Health, Inc. compare | 68.4% |
| LNTH Lantheus Holdings, Inc. compare | 61.3% |
| ELAN Elanco Animal Health Incorporated | 55.4% |
| RDY Dr. Reddy's Laboratories Ltd compare | 49.2% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 40.2% |
| VTRS Viatris Inc. compare | 35.3% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ELAN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement